We own a stock here called Jubilant Pharmova. The company was given a grant from the US government to create a manufacturing facility on the US soil and the US government would have the right of first refusal on production on the facility. And when the US government does not want to source material from that facility, the company is free to manufacture other materials and sell it to whoever they wish to sell.
Nifty rally not sustainable on few big names, broader participation essential: Rahul Ghose of Hedged.in
The December weekly closing formed a neutral candle, reflecting indecisiveness in the market due to the holiday season. Short-term support is around 23,200–23,300, with potential
December 29, 2024